Showing results (481-490 of 658) with videos related to
Sort By:
Pageof 66
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 1, 2013
Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimensYoung Goo Kim, Soyoun Jeon, Ga-Yeong Sin, et al.Genes & Development|December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaKrishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.Neuro-Oncology|January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastomaMekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.Journal of Neuro-Oncology|April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)Mariko DeWire, Maryam Fouladi, David C Turner, et al.International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.Neuro-Oncology|January 3, 2018
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordomaShuyu Hao, Hua Song, Wei Zhang, et al.Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.Acta Neuropathologica|February 22, 2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.Pageof 66